Creo Medical Group PLC
Research Creo Medical Group PLC (CREO) on Bullrun: market cap GBX 6.00B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCREO
- ExchangeLSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryMedical Devices
- CurrencyGBX
- Market capGBX 6.00B
- Financial periodFY2025
- RevenueGBP 6.00M
- Revenue growth50.0%
- Net incomeGBP 5.30M
- Free cash flow-GBP 20.00M
- Gross margin40.0%
Valuation Snapshot
latest market cap is GBX 6.00B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | GBP 6.00M | GBP 5.30M | -GBP 20.00M | 40.0% | 0.01 | GBP 12.40M | GBP 4.10M | GBP 50.00M |
| FY2024 | GBP 4.00M | -GBP 28.70M | -GBP 22.60M | 47.5% | -0.08 | GBP 8.70M | GBP 4.40M | GBP 42.40M |
| FY2023 | GBP 4.00M | -GBP 21.70M | -GBP 23.20M | 57.5% | -0.07 | GBP 3.00M | GBP 8.30M | GBP 59.80M |
| FY2022 | GBP 27.20M | -GBP 26.90M | -GBP 28.20M | 48.5% | -0.14 | GBP 13.10M | GBP 11.70M | GBP 49.30M |
| FY2021 | GBP 25.16M | -GBP 24.60M | -GBP 32.13M | 46.0% | -0.14 | GBP 43.53M | GBP 10.56M | GBP 73.32M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-17 | GBX 6.00B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 GBX.
About Creo Medical Group PLC
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. It also offers Speedboat Inject, an energy multimodal instrument for endoscopy;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Creo Medical Group PLC's market cap?
Creo Medical Group PLC's market capitalization is GBX 6.00B.
What does Creo Medical Group PLC do?
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope.